US Patent Issued to AGENEBIO on Jan. 20 for "Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,819, issued on Jan. 20, was assigned to AGENEBIO INC. (Baltimore).

"Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment" was invented by Belew Mekonnen (Gilbertsville, Pa.), John A. Butera (Clarksburg, N.J.), Jianxing Huang (Bethlehem, Pa.) and Hemantbhai Patel (Piscataway, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those benzodiazepine derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with central nervous system (CNS) disorders. In...